Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma

Clinical trial NCT05248633 · RECRUITING

Trial details

NCT number: NCT05248633
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solitary Plasmacytoma

Start date: 2022-04-21
Primary completion: 2026-04-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.